| Date Filed | Type | Description |
| 06/08/2023 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 10,976 shares
@ $0
Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
| 01/12/2023 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 16,267 shares
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 3,395 shares
@ $0 |
|
| 01/05/2022 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 2,949 shares
@ $0 |
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2020 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.05, valued at
$202.5k
|
|
| 11/09/2020 |
3
| Benton Susan (Director) has filed a Form 3 on REXAHN PHARMACEUTICALS, INC. |
| 09/25/2006 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |